Skip to main content
OpenTrials
Completed

NCT Number: NCT03042845

Randomized Comparison of JUDkins vs tiGEr Catheter in Coronary Angiography Via the Right Radial Artery: the JUDGE Study

The investigators aim to assess safety and efficiency of Tiger II (5Fr; Terumo Interventional Systems, Somerset, New Jersey) vs Judkins (5Fr; 3.5L/4R, Medtronic Co) catheters, in coronary angiography via the right transradial route. This is a prospective, randomized, two-centre, study of parallel design. Consecutive patients with acute coronary syndrome (ACS), eligible for non-urgent coronary angiography, are randomized after successful cannulation of right radial artery and informed consent to either Tigger II or Judkins 3.5L/4R catheters.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Patras University Hospital, Pátrai, Achaia, Greece

Loading trial locations.

About this study

From the entrance of the first diagnostic catheter into the sheath and until the completion of the diagnostic coronary angiography will be the measurement of the endpoints of the study.

In case of failure to complete the coronary angiogram with the catheter study a crossover to the other catheter of the study will take place except in cases of severe spasm, where catheter choice will be at the discretion of the operator. In case of failure of the other study's catheter, next catheter's selection will be at operator's discretion. Patients included in the study, who do not process to adhoc PCI, will be monitored with baseline creatinine and creatinine value at day 2 or 3 after coronary angiography.

In all angiography films will be conducted offline analysis by two experienced operators for scoring opacification grade and coronary ostium contact with the catheters used.

DEFINITIONS Mild spasm Spasm causing well tolerated local pain Moderate spasm Spasm which causes severe pain but the handling of catheters remains satisfactory Severe spasm Spasm that leads to change diagnostic catheter or access site Duration of coronary angiogram Is defined as the time from the insertion of the first diagnostic coronary catheter in the sheath to the exit of the last diagnostic catheter from the sheath Radiation time Radiation time from the insertion of the first diagnostic coronary catheter in the right radial sheath to the exit of the last diagnostic catheter from the sheath Dose area product (DAP) DAP from the insertion of the first diagnostic coronary catheter in the sheath to the exit of the last diagnostic catheter from the sheath Contrast volume Contrast volume (ml) used from the insertion of the first diagnostic coronary catheter in the sheath to the exit of the last diagnostic catheter from the sheath Contrast induced nephropathy (CIN) Relative increase ≥25% from baseline or absolute increase ≥ 0.5mg/dl of serum creatinine within 48-72 hours of intravenous contrast administration Opacification grade 0=poor/non-diagnostic

  • moderate opacification only in systole or diastole
  • moderate opacification throughout cardiac cycle
  • complete opacification but not throughout cardiac cycle
  • complete opacification throughout cardiac cycle Catheter contact with coronary ostium

0=none and non-diagnostic study

1=none but diagnostic study 2=non-coaxial contact 3=coaxial contact Catheter stability within the coronary ostium 0=no catheter's steady engagement of the ostium throughout the angiographic view

1=catheter's steady engagement of the ostium throughout the angiographic view Catheter failure Completion of coronary angiogram after study catheter crossover with or without right radial access site crossover Based on pilot data and previously published data we hypothesized that Tiger catheter use will lead to an absolute decrease of at least 5 ml in contrast volume compared with Judkins catheters (48 and 53 ml for Tiger και Judkins catheters respectively, with estimated standard deviation of 17 for both). With a 2-sided alpha of 0.05, group sample sizes of 316 and 316 will achieve 95% power to detect this difference.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Written informed consent
  • Indication for non-urgent coronary angiography
  • Successful cannulation of right radial artery
  • Availability of both Tiger and JL3.5/JR4 catheters

Exclusion criteria

  • Indication for urgent coronary angiography (ST-elevation myocardial infarction or non ST-elevation myocardial infarction with indication for coronary angiogram within 2 hours)
  • Hemodynamic instability
  • Non palpable right coronary artery
  • Abnormal Allen test
  • Prior coronary artery bypass grafting
  • Chronic kidney disease or dialysis

Treatment and study plan

Tiger cardiac catheter

Device

Tiger cardiac catheter

Judkins 3.5L/4R cardiac catheters

Device

Judkins 3.5L/4R cardiac catheters

Primary outcomes

  1. Contrast volume

    Time frame: End of coronary angiography

    Contrast volume (in ml) between groups used for completion of coronary angiogram in intention to treat analysis analysis

Secondary outcomes

  1. Contrast volume

    Time frame: End of coronary angiography

    Contrast volume (in ml) between groups used for completion of coronary angiogram in per protocol analysis

  2. Dose Area Product (DAP)

    Time frame: End of coronary angiography

    DAP (cGy*cm2) between groups in intention to treat and per protocol analysis

  3. Fluoroscopy time

    Time frame: End of coronary angiography

    Fluoroscopy time (min) between groups in ITT and per protocol analysis

  4. Contrast induced nephropathy (CIN)

    Time frame: End of coronary angiography

    CIN rate between groups in ITT and per protocol analysis

  5. Catheter failure

    Time frame: End of coronary angiography

    Catheter failure rate between groups

  6. Severe spasm

    Time frame: End of coronary angiography

    Severe spasm rate between groups

  7. Coronary angiogram time

    Time frame: End of coronary angiography

    Duration of coronary angiogram between groups in ITT and per protocol analysis

  8. Opacification grade

    Time frame: End of coronary angiography

    Opacification grade for LAD, LCX and RCA between study catheters

  9. Contact to coronary ostium

    Time frame: End of coronary angiography

    Contact to left and right coronary ostium between study catheters

  10. Stability within the coronary ostium

    Time frame: End of coronary angiography

    Catheter's steady engagement of the ostium throughout the angiographic view

Sponsors and collaborators

Lead sponsor

University Hospital of Patras

Other

Registry information

Acronym: JUDGE

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Feb 3, 2017
Registry last updated
May 30, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.